scholarly journals A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

2015 ◽  
pp. 1349 ◽  
Author(s):  
Ernie Anand ◽  
Lovisa Berggren ◽  
Claudia Deix ◽  
Ágoston Tóth ◽  
David McDonnell
Sign in / Sign up

Export Citation Format

Share Document